By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Humacyte, Inc. 

3316 Carriage Trail

Hillsborough  North Carolina  27278  U.S.A.
Phone: 919-806-4599 Fax:



Start Up

Company News
Humacyte Founder Laura Niklason, M.D., Ph.D. Recognized On Fortune Magazine’s List Of Leaders Transforming Health And Medicine 4/26/2017 7:46:32 AM
Humacyte Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Expedited Review Designation For HUMACYL In Vascular Access For Hemodialysis 3/20/2017 10:15:48 AM
Humacyte Commences U.S. Phase II Arterial Bypass Clinical Trial 12/29/2016 8:18:14 AM
Humacyte Earns Spot On CNBC Disruptor 50 List 6/7/2016 11:32:12 AM
Humacyte’s Phase II Bioengineered Blood Vessel Study Results Published in The Lancet 5/13/2016 8:23:48 AM
Humacyte Commences Phase III Clinical Trial Of Human Acellular Vessel 5/13/2016 8:22:09 AM
Humacyte Chief Medical Officer Jeffrey H. Lawson M.D., Ph.D. Elected To Fellowship In The American Surgical Association 4/25/2016 10:47:29 AM
Humacyte Founder Laura Niklason, M.D., Ph.D. To Present At The American Heart Association Scientific Sessions 11/2/2015 9:56:10 AM
Humacyte Founder Laura Niklason, M.D., Ph.D. Elected To National Academy Of Medicine 10/20/2015 10:29:58 AM
Humacyte Nabs $150 Million Series B Financing 10/20/2015 10:18:36 AM